Newsroom

Sorted by: Latest

-

Collabrios Health Continues to Invest in the Future of Aging with Appointment of Chief Medical Officer

LAFAYETTE, Calif.--(BUSINESS WIRE)--Collabrios Health, a purpose-built software solution that unifies the entire care delivery journey and is trusted by more than 135 PACE centers nationwide, today welcomed Dr. Rebecca Schreiner, MD, as Chief Medical Officer (CMO), strengthening the company’s executive leadership team and deepening its commitment to clinically driven innovation for the PACE community and aging services. In this role, Dr. Schreiner will serve as the clinical and strategic leader...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Growth Strength UCITS ETF 19.01.2026 FTGS.LN IE000YZLMXT9 25,002.00 USD 566,230.15 22.647  ...
-

Why We Gather: Hilton Reveals Behavioral, Emotional and Cultural Drivers Defining 2026 Meetings and Events

MCLEAN, Va.--(BUSINESS WIRE)--As technology and artificial intelligence (AI) rapidly redefine how we connect, today’s most impactful meetings and events continue to be anchored in authentic, in-person moments that digital platforms can’t replicate. Today, Hilton introduces the Why We Gather Report, a new special section of its 2026 Trends Report, which explores the behavioral, emotional, and cultural shifts redefining how people are planning to connect in 2026 through meetings and events. Groun...
-

Fiserv to Release Fourth Quarter Earnings Results on February 10, 2026

MILWAUKEE--(BUSINESS WIRE)--Fiserv to Release Fourth Quarter Earnings Results on February 10, 2026...
-

Worldwide Clinical Trials Enters Definitive Agreement to Acquire Catalyst Clinical Research

RESEARCH TRIANGLE PARK, N.C. & NOTTINGHAM, England--(BUSINESS WIRE)--Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research, LLC , a specialized oncology CRO....
-

Scribe Therapeutics Projected to Enter the Clinic in Mid-2026 with STX-1150, a PCSK9-targeting CRISPR Epigenetic Silencing Therapy for Durable LDL-C Reduction

ALAMEDA, Calif.--(BUSINESS WIRE)--Scribe projected to enter the clinic in mid-2026 with STX-1150, a PCSK9-targeting CRISPR epigenetic silencing therapy for durable LDL-C reduction...
-

Armis Blocks 99% of Cyber Attacks and Delivers 351% ROI, Omdia Finds

SAN FRANCISCO--(BUSINESS WIRE)--Armis, the cyber exposure management & security company, today announced the findings of a new report by technology research and advisory firm, Omdia, analyzing the economic benefits of Armis Centrix™, the Armis Cyber Exposure Management Platform. Analysts found that Armis enables global organizations to achieve 351% annual ROI by combining comprehensive cyber risk management with streamlined operations and significant cost savings. “This study validates the...
-

Maxell Develops All-Solid-State Battery Power Module Compatible with ER Battery Size

TOKYO--(BUSINESS WIRE)--Maxell has developed an all-solid-state battery power module which matches the same size and output voltage as a lithium thionyl chloride battery....
-

poLight ASA Launches MLens® Off-The-Shelf Lenses Delivering Tunable Optics Focusing Capabilities for Industrial Machine Vision Applications

TØNSBERG, Norway--(BUSINESS WIRE)--poLight ASA today announced its new MLens® off-the-shelf (OTS) portfolio of M12 focusing camera lens for industrial machine vision applications....
-

Tangoe and Kubex Partner to Deliver Advanced Cloud and Kubernetes Optimization Through Tangoe One Cloud

INDIANAPOLIS & TORONTO--(BUSINESS WIRE)--Tangoe & Kubex partner to help enterprises improve FinOps maturity & optimize Kubernetes, IaaS & GPU resources across cloud infrastructure....